These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24999122)

  • 1. Influence of the separation of prescription and dispensation of medicine on its cost in Japanese prefectures.
    Yokoi M; Tashiro T
    Glob J Health Sci; 2014 Apr; 6(4):57-62. PubMed ID: 24999122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription, Dispensation, and Generic Medicine Replacement Ratios: Influence on Japanese Medicine Costs.
    Yokoi M; Tashiro T
    Glob J Health Sci; 2015 May; 8(1):29-35. PubMed ID: 26234979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Japanese Community Pharmacists' Dispensing Influences Medicine Price Reduction more than Prescription Numbers.
    Yokoi M; Tashiro T
    Glob J Health Sci; 2016 Sep; 8(9):54314. PubMed ID: 27157157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012.
    Ha D; Song I; Lee EK; Shin JY
    BMC Health Serv Res; 2018 May; 18(1):327. PubMed ID: 29724220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discounted drug prices for hospitals: result in prescriptions for expensive drugs in the community.
    Prescrire Int; 2015 Sep; 24(163):223. PubMed ID: 26417639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Price difference as a predictor of the selection between brand name and generic statins in Japan.
    Takizawa O; Urushihara H; Tanaka S; Kawakami K
    Health Policy; 2015 May; 119(5):612-9. PubMed ID: 25697888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the introduction of government use licenses on the drug expenditure on seven medicines in Thailand.
    Mohara A; Yamabhai I; Chaisiri K; Tantivess S; Teerawattananon Y
    Value Health; 2012; 15(1 Suppl):S95-9. PubMed ID: 22265076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Older people's perceptions of prescription medicine costs and related costs: a pilot study in New Zealand.
    Tordoff J; Bagge M; Ali F; Ahmed S; Choong JN; Fu R; Joe A; Nishtala P
    J Prim Health Care; 2014 Dec; 6(4):295-303. PubMed ID: 25485325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deeply discounted medications: Implications of generic prescription drug wars.
    Czechowski JL; Tjia J; Triller DM
    J Am Pharm Assoc (2003); 2010; 50(6):752-7. PubMed ID: 21071323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Emergency Department Pilot Study to Save Money for Patients through use of Retail Pharmacy Generic Drug Discount Programs.
    Dalawari P; Kantipudi A; Fitzgerald J
    J Health Care Poor Underserved; 2018; 29(4):1356-1367. PubMed ID: 30449751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differences between prescription and dispensing of generic medicines in primary care. When the exception is the rule].
    Díez JI; Benounna H; Mayol CV; García RM
    Gac Sanit; 2007; 21(5):404-6. PubMed ID: 17916305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic script share and the price of brand-name drugs: the role of consumer choice.
    Rizzo JA; Zeckhauser R
    Int J Health Care Finance Econ; 2009 Sep; 9(3):291-316. PubMed ID: 19130220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Students and Doctors are Unaware of the Cost of Drugs they Frequently Prescribe.
    Schutte T; Tichelaar J; Nanayakkara P; Richir M; van Agtmael M
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):278-283. PubMed ID: 27639184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The generic drug market in Japan: will it finally take off?
    Iizuka T; Kubo K
    Health Econ Policy Law; 2011 Jul; 6(3):369-89. PubMed ID: 21205400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing.
    Bazalo G; Weiss RC
    Consult Pharm; 2012 Apr; 27(4):269-73. PubMed ID: 22498986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restrictions on the reimbursement policy with regard to retail marketing of medicinal products in Poland.
    Zimmermann A
    Acta Pol Pharm; 2013; 70(2):339-43. PubMed ID: 23614291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing Pharmaceutical Price Spikes Through Generic Preclearance.
    Sachs RE
    J Leg Med; 2019; 39(2):169-176. PubMed ID: 31503530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.